Inhibikase Therapeutics (IKT) EPS (2020 - 2026)
Inhibikase Therapeutics (IKT) EPS from Dec 31, 2020 to Mar 31, 2026. The TTM Inhibikase Therapeutics (IKT) EPS is -$0.51. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Inhibikase Therapeutics (IKT) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -14.81% |
| 3 Years TTM | -8.76% |
| 5 Years TTM | +6.04% |
| All Time TTM | -8.41% |
Annual EPS change of Inhibikase Therapeutics (IKT)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.12 | -66.15% |
| 2025 | -$0.37 | -7.64% |
| 2024 | -$0.40 | -22.63% |
| 2023 | -$0.51 | -28.33% |
| 2022 | -$0.72 | +21.69% |
| 2021 | -$0.59 | +107.35% |
| 2020 | -$0.28 | N/A |